Comparison of Free Gingival Graft and Linear Incision for Connective Tissue
Launched by FEDERAL UNIVERSITY OF RIO GRANDE DO SUL · Apr 10, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical techniques to help cover exposed tooth roots caused by gum recession, which can affect both appearance and dental health. Specifically, it compares a free gingival graft and a connective tissue graft to see which one provides better results. The trial will involve 24 healthy adults aged 18 and older, who need treatment for gum recession on at least two teeth on each side of their mouth. Participants will be required to have similar conditions on both sides to ensure fair comparisons.
If you join this study, you'll first receive dental cleaning and instructions on how to maintain good oral hygiene. Then, you will undergo surgery on one side of your mouth, followed by a waiting period of about 30 days before the second side is treated. Throughout the following year, your recovery will be monitored, and various outcomes like gum health and quality of life will be assessed. This trial is looking for individuals who do not have certain health conditions, like diabetes or active gum disease, and who do not smoke. Overall, this research aims to find the best way to restore gum health and improve your smile.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 or older requiring root coverage in bilateral multiple recessions involving at least two teeth on each side of the mouth will be included. The number of teeth to be covered must be equal on both sides to avoid imbalance in patient-centered comparisons. Recessions should be RT1 type according to the 2017 Workshop on the Classification of Periodontal Conditions and Diseases (Jepsen et al. 2018) and without non-carious cervical lesions.
- Exclusion Criteria:
- Individuals will not be considered eligible if they:
- • Present any form of immunological compromise;
- • Have diseases or systemic conditions contraindicating surgical procedures or affecting periodontal healing pattern, such as diabetes and autoimmune diseases;
- • Present active periodontitis, defined by presence of \>=10% subgingival bleeding and probing depth and clinical attachment loss proximal \>4mm (Tonetti et al. 2018);
- • Are current or ex-smokers;
- • Have allergies to ibuprofen and chlorhexidine digluconate.
About Federal University Of Rio Grande Do Sul
The Federal University of Rio Grande do Sul (UFRGS) is a leading academic institution in Brazil, renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, UFRGS leverages its extensive network of researchers and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university is dedicated to conducting rigorous and ethically sound clinical studies, fostering collaborations with healthcare professionals, industry partners, and regulatory bodies to ensure the highest standards of scientific integrity and public health impact.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rs, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported